On March 4, 2011, the US Food and Drug Administration warned the public of the grave complications Topiramate can have when taken during pregnancy. Listed under the brand Topomax, the prescription drug Topiramate effectively reduces the likelihood of epileptic seizures and migraine attacks. FDA studies, however, have shown that it increases risk of injury to a fetus, potentially resulting in birth defects like Hypospadias, a condition in which the urethra, the tube through which urine is drained from the bladder, is found at the underside of the male organ instead of at its tip.
If you have taken Topiramate during your pregnancy and have given birth to a baby with a physical deformity, you should considering contacting an attorney and allow him or her to study your case. If your child’s defect is determined to have been caused by Topiramate, then under the law you are allowed to file a claim against this product’s manufacturer and receive compensation for the damages you and, especially, your child have gone through. Though neither a Topamax lawsuit nor any amount of compensation will ever erase the marks of injury, your child may, at least, be able to have the financial security that is necessary to afford surgical procedures and further medical treatments.
First introduced in the market by Johnson & Johnson in 1996, Topiramate proved to be an effective prescription drug, providing epileptics and those suffering from migraines their needed relief. The drug also seemed to have worked where all other medications failed. It was manufactured in two different forms: pill and powder (allowing it to be mixed in food easily). To reduce seizures and migraine attacks, Topiramate suppressed all seizure or pain-causing signals coming from the nerves. Despite being an effective treatment for its intended conditions, however, the effects of Topiramate can be devastating for families.
Though the FDA never banned the prescription, sale, or use of Topiramate, it advised medical authorities and professionals to observe extreme care when prescribing the drug, especially to pregnant women, suggesting that it may only be recommend to expecting mothers if its benefits undoubtedly outweigh the risks.